PIN143 Analysis of the Time to Market Access in Bulgaria of New Daa Medicines for Chronic HCV Infection Authorized UNDER the EMA Specific Procedures for EARLY Access
| Autor: | Tsekov, I., Topova, B., Doychev, P., Dimitrova, M., Petrova, G. |
|---|---|
| Zdroj: | In Value in Health December 2020 23 Supplement 2:S567-S567 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect